Diarrhoea, nausea, vomiting, abdominal pain, loss of appetite, flatulence, bloating, indigestion, headache, taste disturbance

Prescription medicine. Risk of hypoglycaemia increases when used with insulin or sulfonylureas (may need dose adjustment). Metformin may rarely cause lactic acidosis—risk higher with kidney impairment, dehydration, severe infection, alcohol use, liver disease, heart failure, or hypoxia; stop and seek care if fast breathing, severe weakness, abdominal pain, or drowsiness occur. Monitor kidney function before and during therapy; avoid in severe renal impairment. Temporarily stop metformin before/after iodinated contrast imaging or major surgery as advised by a doctor. Use caution in elderly and in vitamin B12 deficiency (long‑term metformin can reduce B12).

Alcohol (increases lactic acidosis risk with metformin), iodinated contrast media, carbonic anhydrase inhibitors (e.g., topiramate, acetazolamide), cimetidine, diuretics, ACE inhibitors/ARBs, corticosteroids, beta‑agonists, thyroid hormones, insulin and sulfonylureas (increased hypoglycaemia risk), other antidiabetic medicines

Store below 25°C in a cool, dry place. Protect from moisture and light. Keep out of reach of children.

Voglibose 0.3 mg + Metformin tablets (various brands): Vogli-M 0.3, Voglimet 0.3, Volibo M 0.3, Vobose M 0.3, Voglitor M 0.3